Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C 1Hepatitis B 1Carcinoma, Hepatocellular 1Acquired Immunodeficiency Syndrome 1

Interventions

entecavir 4Lamivudine 4Sorafenib 2polysaccharide MGN3 1navitoclax 1lens intermediate filament proteins 1human papillomavirus vaccine, L1 type 16, 18 1hepatitis B hyperimmune globulin 1adefovir dipivoxil 1Tumor Necrosis Factor-alpha 1Tetanus Toxoid 1Rapid Diagnostic Tests 1Raltegravir Potassium 1Radiofrequency Ablation 1Polymorphism, Genetic 1Pneumococcal Vaccines 1Pharmaceutical Preparations 1PHY 906 1Measles-Mumps-Rubella Vaccine 1Heptavalent Pneumococcal Conjugate Vaccine 1Hepatitis B Vaccines 1Enzyme-Linked Immunosorbent Assay 1Engerix-B 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hepatitis B × Rapid Diagnostic Tests × Clear all
NCT01790633 2016-12-13

OPTISCREEN-III

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

Phase NA Completed
327 enrolled 9 charts
Gastrointestinal

Acquired Immunodeficiency Syndrome, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡